Inferra AI / Company / XNDU

Xanadu Quantum Technologies Limited

XNDU · Information Technology

Last earnings Aug 5, 2026

Key results

Revenuequarter

$1.5 million

Revenue was $1.5 million, compared to $2.8 million in the first quarter of 2026 and $1.1 million in the second quarter of 2025, with the year-over-year increase primarily driven by DARPA Stage B revenue Research and development ( R D ) expense was $19.7 million

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

AI analysis

Q2 2026 · reported Aug 5, 2026

Based on: Earnings release (6-K exhibit) + parent 6-K — transcript not held

Revenue · Q2 2026
$1.5M
-46.4% -$1M vs prior quarter computed from stated figures
EX-99 · Aug 5, 2026

The quarter in charts

Revenue — quarterly

As stated

0123$2.8MPrior quarter$1.5MQ2 2026

EX-99 · Aug 5, 2026 Statement values as stated in the release.

Headline figures

MetricQ2 2026Prior qtrYear ago
Revenue$1.5 million$2.8 million—

EX-99 · Aug 5, 2026

Guidance · company-stated

No guidance located in the held release

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

Based on Xanadu's current operating plan, management believes that the existing cash and cash equivalents will be sufficient to fund operations, research and development ("R&D") activities, and capital expenditure requirements for at least 12 months from the date these condensed consolidated financial statements are issued.

What changed vs last quarter

  • Revenue -$1M (-46.4%) computed from stated figures
General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

operations expansion Announced a significant expansion of U.S

Based on: Earnings release (6-K exhibit) + parent 6-K — transcript not held

Guidance & outlook

No guidance located in the held release

Capital allocation

Based on Xanadu's current operating plan, management believes that the existing cash and cash equivalents will be sufficient to fund operations, research and development ("R&D") activities, and capital expenditure requirements for at least 12 months from the date these condensed consolidated financial statements are issued.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

Strategy & priorities

That balance sheet gives us the runway to keep investing in the engineering talent and wafer capacity our roadmap requires.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

operations expansion Announced a significant expansion of U.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

Strategic collaborations and partnerships Partnered with Oak Ridge National Laboratory to bring PennyLane onto the Frontier exascale supercomputer re-signed a multi-year collaboration with Rolls-Royce on computational fluid dynamics and aerodynamics and continued research with the Fidelity Center for Applied Technology (FCAT), alongside advanced-stage engagements with several major banks.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

Launched a joint quantum machine learning and workforce-training initiative with Lockheed Martin under its Quantum Talent Pipeline deepened engagement with Los Alamos National Laboratory's 2026 Summer School and joined the Unitary Foundation.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

Net proceeds are used for working capital and general corporate purposes, which help fund the continued development of the Company's quantum computing technology roadmap.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

Risks & headwinds

These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause the Company s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such statements.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

The forward-looking statements contained in this Quarterly Report reflect our current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause actual results to differ significantly from those expressed in any forward-looking statement.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

headcount and the benefits of the Albany expansion; the expected benefits of the algorithmic breakthrough in Quantum Read Only Memory; and the outcome of any known and unknown litigation and regulatory proceedings.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

and Canadian foreign investment review requirements, including review by the Committee on Foreign Investment in the United States and the Investment Canada Act, and export controls applicable to quantum computing technology; the impact of changes in international trade relations and tariffs on our supply chain and operations; and 4 the risks associated with the rapid expansion of our U.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

These forward-looking statements speak only as of the date of this Quarterly Report and are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by the forward-looking statements.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

Should one or more of these risks or uncertainties materialize, or should any of the assumptions made in making these forward-looking statements prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.

SEC original ↗Xanadu Quantum Technologies Limited — Earnings release (6-K exhibit)EX-99Aug 5, 2026

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Documents

Filings

14 documents

Earnings releases

4 documents

Presentations

0 documents

No presentations for Xanadu Quantum Technologies Limited are held in this edition of the library.

Transcripts

0 documents

No transcripts for Xanadu Quantum Technologies Limited are held in this edition of the library.

See also the earnings calendar for every tracked company’s next earnings date.